Friday 5 March 2021
الصفحة الرئيسية      كل الأخبار      اتصل بنا      RSS      English
bizbahrain - منذ 1 أشهر

Pfizer-BioNTech and Moderna to earn $14.7B from COVID-19 vaccines sales by 2023

The year 2021 is set to become quite a year for the pharma companies leading the COVID-19 vaccine race, with significant revenues on the line. As some of the most significant players in the market, pharma giants Pfizer and Moderna are set for the lion s share of 2021 vaccine sales. According to data presented by [ ]


آخر الأخبار
هشتک:   

Pfizer

 | 

BioNTech

 | 

Moderna

 | 

COVID

 | 

vaccines

 | 

sales

 | 

مصادر